How Alphaviral Vaccines Work
Author Information
Author(s): Tanja I Näslund, Linda Kostic, Eva KL Nordström, Margaret Chen, Peter Liljestöm
Primary Institution: Karolinska Institutet
Hypothesis
Are innate signaling pathways important for the immunogenicity of alphaviral replicon-based vaccines?
Conclusion
Alphaviral replicon-based vectors activate multiple innate signaling pathways that both enhance and limit the immune response.
Supporting Evidence
- Alphaviral replicon-based vectors induce strong immune responses.
- Type I interferon can suppress T cell responses after vaccination.
- IRF3 is crucial for a robust immune response.
Takeaway
This study shows that certain immune signals help vaccines work better, but too much of these signals can actually make the vaccine less effective.
Methodology
Mice were immunized with DREP or VREP and immune responses were measured using ELISpot.
Limitations
The study primarily used mouse models, which may not fully represent human responses.
Participant Demographics
Female mice, 6-12 weeks old.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website